Literature DB >> 8642091

Leishmaniasis.

S A Grevelink1, E A Lerner.   

Abstract

Leishmaniasis is a protozoan disease whose diverse clinical manifestations are dependent both on the infecting species of Leishmania and on the immune response of the host. Transmission of the disease occurs through the bite of a sand fly infected with Leishmania parasites. Infection may be restricted to the skin in cutaneous leishmaniasis, limited to the mucous membranes in mucosal leishmaniasis, or spread throughout the reticuloendothelial system in visceral leishmaniasis or kala azar. Three rare clinical variants of cutaneous leishmaniasis include diffuse cutaneous leishmaniasis, leishmaniasis recidivans, and post-kala-azar dermal leishmaniasis.

Entities:  

Mesh:

Year:  1996        PMID: 8642091     DOI: 10.1016/s0190-9622(96)80121-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.

Authors:  Marta Gontijo Aguiar; Aline Márcia Machado Pereira; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

2.  Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.

Authors:  Samuel Vidal Mussi; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

3.  [Cutaneous leishmaniasis].

Authors:  E von Stebut; C Sunderkötter
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 4.  [Skin and soft tissue infections due to non-tuberculous mycobacteria: etiology, epidemiology, pathogenesis, differential diagnostic aspects and therapeutic recommendations].

Authors:  Pietro Nenoff; Georgi Tchernev; Uwe Paasch; Werner Handrick
Journal:  Wien Med Wochenschr       Date:  2011-09

Review 5.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India.

Authors:  Kanika Khandelwal; Ram Awatar Bumb; Rajesh Dutt Mehta; Himanshu Kaushal; Claudio Lezama-Davila; Poonam Salotra; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

7.  Miltefosine (Impavido): the first oral treatment against leishmaniasis.

Authors:  H Sindermann; S L Croft; K R Engel; W Bommer; H J Eibl; C Unger; J Engel
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

8.  The biology and control of leishmaniasis vectors.

Authors:  David M Claborn
Journal:  J Glob Infect Dis       Date:  2010-05

9.  Ocular involvement in cutaneous leishmaniasis four cases with blepharoconjunctivitis.

Authors:  Ahmet Satici; Bulent Gurler; Gonul Aslan; Irfan Ozturk
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis.

Authors:  Mislaine Adriana Brenzan; Celso Vataru Nakamura; Benedito Prado Dias Filho; Tânia Ueda-Nakamura; Maria Claudia M Young; Diógenes Aparício Garcia Cortez
Journal:  Parasitol Res       Date:  2007-05-05       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.